🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-arm phase I dose-escalation study designed to...
Status
Recruiting
Location
The First Affiliated Hospital Zhejiang University School of Medicine
Start Date
2025-05-12
Trial ID
NCT06912152
Treatments Being Tested
This is a Phase II trial to evaluate the safety, tolerability, efficacy, an...
Status
Not Yet Recruiting
Location
The Johns Hopkins Sidney Kimmel Cancer Center
Start Date
2026-06-30
Trial ID
NCT07386002
Treatments Being Tested
MT027 is an off-the-shelf, allogeneic chimeric antigen receptor T cell (UCA...
Status
Not Yet Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2025-01-01
Trial ID
NCT06742593
Treatments Being Tested
The goal of this Phase I/II observational and interventional platform study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07307053
This study is a single-arm, dose-escalation, investigator-initiated explora...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2025-03-15
Trial ID
NCT07004647
Treatments Being Tested
The clinical protocol plans to preset three dose groups, namely 1×10⁷ cells...
Status
Not Yet Recruiting
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Start Date
2025-01-01
Trial ID
NCT06737146
Treatments Being Tested
This is a phase I open label, single-arm, dose-escalation study to evaluate...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-05-15
Trial ID
NCT06726564
Treatments Being Tested